WeVote
Log In

Bill

Bill

SB 262

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

153rd General Assembly (2025-2026) Introduced by Ron Gray and 3 co-sponsors

Delaware bill to amend controlled substances laws; specific changes unclear pending committee review and public access to full text.

Adopted in lieu of the original bill SB 262, and Assigned to Health & Social Services Committee in Senate
0
WeVote Research Nonpartisan
Bill Summary · SB 262

Legislative bill overview

SB 262 proposes amendments to Delaware's Uniform Controlled Substances Act (Title 16 of the Delaware Code), though the specific provisions are not detailed in the available information. The bill was introduced in March 2026 and assigned to the Health & Social Services Committee for review. Without access to the full bill text, the exact nature of the proposed changes cannot be determined.

Why is this important

Amendments to controlled substances legislation can significantly affect drug policy, criminal penalties, medical access to regulated drugs, and law enforcement priorities in Delaware. Changes to this framework influence public health outcomes, criminal justice outcomes, and healthcare practices across the state.

Potential points of contention

  • Lack of transparency: The specific amendments are not publicly detailed here, making it difficult for stakeholders and the public to assess potential impacts or voice informed positions
  • Balance between public health and criminal justice: Any changes likely involve tensions between treatment-focused approaches versus enforcement-focused approaches
  • Medical access concerns: Amendments could affect physician prescribing authority, patient access to pain management medications, or addiction treatment options

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.